Drug Database
Back to search

Netherlands· NL-47c9a15449f7

Orkambi 100 mg/125 mg, Granulaat in sachet

A ivacaftor and lumacaftor product containing ivacaftor + lumacaftor, registered in Netherlands by Vertex Pharmaceuticals (Ireland) Limited. The same ATC class is registered in 16 of our 19 countries.

ATC R07AX30

Checked against CBG-MEB (Netherlands) on

Informational only — not a medical device.

SOURCE REGISTER · NLCBG-MEB (Netherlands)normalisedOrkambi 100 mg/125 mg, Granulaat in s…ATCR07AX30REGISTER NO.NL-47c9a15449f7PACKS LISTED1CHECKEDSeptember 29, 2026
Compare price across countriesPer daily dose · free accountAsk the assistant about ivacaftor + lumacaftorAnswers with sources · free accountCheck interactionsSeverity free · mechanism on Growth

Where it is registered

Ivacaftor and lumacaftor is registered in 16 of 19 countries.

Countries holding a registration under ATC R07AX30 (ivacaftor and lumacaftor), each read from that country’s own register.

  • This record: Netherlands, from CBG-MEB (Netherlands)
  • 11 of them publish a price we can compare per daily dose
Search ivacaftor and lumacaftor products by name

Ivacaftor and lumacaftor · ATC R07AX30

16 / 19 countries

  • Belgiumprice
  • Canada
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Franceprice
  • Icelandprice
  • Ireland
  • Italyprice
  • Netherlands
  • Norwayprice
  • Polandprice
  • Spainprice
  • Switzerlandprice
  • United Kingdom
  • United Statesprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

CBG-MEB (Netherlands)
Active substance
IVACAFTOR + LUMACAFTOR
Manufacturer
Vertex Pharmaceuticals (Ireland) Limited
Country
Netherlands (NL)
ATC code
R07AX30
ATC class
Ivacaftor and lumacaftor
Reimbursed
Not published by this register
Source register
CBG-MEB (Netherlands)
Last checked
September 29, 2026

Packs & prices · 1

  • cbg_meb_id
    EU/1/15/1059

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Same medicine, other countries

Ivacaftor and lumacaftor in 13 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All ivacaftor and lumacaftor products

Authorised across Europe · EMA

The same active substance is authorised in 3 EEA countries. Names it is sold under:

  • Iceland · Orkambi
  • Liechtenstein · Orkambi
  • Norway · Orkambi

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of CBG-MEB (Netherlands). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/d0704792-8d45-4e81-9069-87503d32fbf3
GET /v1/drugs/d0704792-8d45-4e81-9069-87503d32fbf3?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Granulaat",
  "route": "Oraal gebruik",
  "soort": null,
  "source": "cbg_meb",
  "smpc_url": "https://www.ema.europa.eu/en/documents/product-information/orkambi-epar-product-information_nl.pdf",
  "strength": null,
  "atc_label": "Ivacaftor and lumacaftor",
  "detail_url": "https://www.geneesmiddeleninformatiebank.nl/nl/cp122669",
  "excipients": [
    "CELLULOSE, MICROKRISTALLIJN (E 460(i))",
    "CROSCARMELLOSE  NATRIUM  (E 468)",
    "HYPROMELLOSEACETAATSUCCINAAT",
    "NATRIUMLAURILSULFAAT",
    "POVIDON K 30 (E 1201)"
  ],
  "substances": [
    "IVACAFTOR",
    "LUMACAFTOR"
  ],
  "leaflet_url": null,
  "authorised_at": "2015/11/19",
  "procedure_number": "EMEA/H/C/003954",
  "dispensing_status": "Uitsluitend recept",
  "registration_number": "EU/1/15/1059",
  "additional_monitoring": "N"
}
API referenceMCP serverPlans

See everything about ivacaftor and lumacaftor.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it freeOpen in the console